Redmile Group, LLC Allakos Inc. Transaction History
Redmile Group, LLC
- $1.53 Billion
- Q2 2024
A detailed history of Redmile Group, LLC transactions in Allakos Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 3,077,828 shares of ALLK stock, worth $4.34 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
3,077,828
Previous 3,451,076
10.82%
Holding current value
$4.34 Million
Previous $4.35 Million
29.23%
% of portfolio
0.2%
Previous 0.17%
Shares
21 transactions
Others Institutions Holding ALLK
# of Institutions
96Shares Held
70.7MCall Options Held
43.8KPut Options Held
1.4K-
Bvf Inc San Francisco, CA16.6MShares$23.3 Million0.51% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$8.67 Million0.58% of portfolio
-
Deep Track Capital, LP Greenwich, CT5MShares$7.05 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$4.96 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.42MShares$4.83 Million0.0% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $119M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...